Alliance Promotion Microbiote
Leading the way in Europe to bring microbiome-based innovations to market.
Created in 2022, Alliance Promotion Microbiote is an independent, non-profit organization. Our goal is to position France as the European leader in the development, production, and commercialization of therapeutic microbiome-based innovations.
APM gathers more than 20 key players from public and private sectors. From bench to bedside, APM encompasses the entire value chain of the microbiome industry.
We work to accelerate the translation of basic research towards market launch of microbiome-based innovations, to meet important medical needs and improve the quality-of-life of millions of patients.
APM works to accelerate the availability of microbiota innovations on the market in order to meet important medical needs and thus improve the quality of life and treatment of patients.
to attract investment
value chain, especially from a
and the European leader in the microbiome industry
Our agile structure
APM is a consensus-driven and collegial organization.
at MaaT Pharma
at Biose Industrie
at Biofortis Europe
Organized into 4 colleges with specific roles
College of Developers
includes entities developing a product with a regulatory status (drug, medical device,
in vitro diagnostic device….).
College of Associates
includes entities such as investment companies financing microbiome companies;
preclinical and clinical research and development companies (CDMO)
working primarily in the microbiota field.
College of Clusters & Institutions
includes organizations such as incubators, life sciences clusters, research
institutes, value-creating entities, SATT, hospitals, clinics, health care institutions,
technology hub, city and regional authorities.
College of Partners
includes structures that could be universities, schools, consortiums,
associations or foundations
APM is currently focused on advancing key topics for microbiome innovations to reach the market, clarifying the regulatory pathways for microbiome-related therapies, and fostering awareness about the key role of the microbiome in health and disease.
Unity is strength. Joining APM means being able to provide input to policy makers, patients’ associations, investors in Europe, and share networking opportunities while contributing to structure the industry. As all companies and institutions have experienced, achieving growth without the support of a structured and powerful ecosystem is a massive challenge. Here, at APM, we are committed to giving a voice to our members on behalf of the industry and providing business intelligence and tools to navigate the field.